C Paul Loehnen, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 500 West Broadway, Missoula, MT 59802 Phone: 406-721-5600 Fax: 406-721-3907 |
News Archive
Medtronic, Inc. announced findings from an economic sub-study of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial published in the European Heart Journal demonstrating for the first time that cardiac resynchronization therapy (CRT) is cost-effective in mildly symptomatic heart failure (HF) patients.
Nektar Therapeutics reported that partner Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) to the United States Food and Drug Administration for the approval of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)].
The editor of a top medical journal says money, and money alone, is having an "unethical influence" on medical science and by so-doing she has upped the pressure on scientists to fully disclose commercial ties by urging the employers of those who don't comply to probe them for possible conflicts of interest.
A recent study by University of Hawai'i at Mānoa researchers revealed that Angiostrongylus cantonensis, the rat lungworm, is widespread in the Hawaiian Islands and its distribution may expand, especially towards higher elevations, as the climate warms.
› Verified 2 days ago